Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]
A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included pa…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer [NA]
This clinical trial update reports completion of a study evaluating chemotherapy and total-body irradiation followed by donor umbilical cord…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma [Phase 1]
This document reports the completion of a Phase 1 trial of NPI-0052 in patients with advanced solid tumor malignancies or refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma [Phase 1]
Phase 1 trial update of NPI-0052 (marizomib) and vorinostat in patients with non-small cell lung cancer, pancreatic cancer, melanoma, lympho…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax [Phase 1]
Phase 1 trial update evaluating the effect of rifampin on navitoclax metabolism; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma [Phase 1]
Open-label Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of GSK1120212 (trametinib) in subjects with solid tum…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab in elderly patients with re…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma [Phase 1]
Phase 1 pharmacokinetics results for oral ixazomib in participants with advanced nonhematologic malignancies or lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Samsung Medical Center-Lymphoma Cohort Study-II
A completed clinical trial update for the Samsung Medical Center Lymphoma Cohort Study II. The study focusing on lymphoma has reached comple…
-
CLINICAL_TRIALS research · 2017-10-18Clinical Trial Update: China Lymphoma Patient Registry Study
The entry notes an ongoing China Lymphoma Patient Registry study sponsored by Jun Zhu, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Proton Radiation for Lymphoma Involving Mediastinum [NA]
A clinical trial evaluating proton radiotherapy for mediastinal lymphoma (NCT01751412) was terminated, with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-10-17Clinical Trial Update: Lonquek for Autologous Stem Cell Mobilization [Phase 1, Phase 2]
Clinical trial update for Lonquek in autologous stem cell mobilization across lymphoma and multiple myeloma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 study evaluating low-dose fludarabine, busulfan, and anti-thymocyte globulin conditioning followed by donor umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial evaluating alefacept in relapsed or refractory cutaneous T-cell lymphoma and peripheral T-cell non-Hodgkin's lymphoma…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab, cyclophosphamide, and G-CSF followed by combination chemotherapy with rituximab and GM-CSF for refractor…
-
CLINICAL_TRIALS research · 2017-08-18Clinical Trial Update: Brazilian Network for Lymphoma Registry
Clinical trial update for the Brazilian Network for Lymphoma Registry (NCT02265497); the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study of oral LBH589 (panobinostat) in adults with advanced hematologic malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells [Phase 1]
A Phase 1 study evaluating infusion of allogeneic cord blood-derived CD19-specific T cells for leukemia and lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Phase 1 trial of Recombinant Human Arginase 1 (rhArg1) in relapsed or refractory leukemia or lymphoma has been terminated. This status updat…
-
CLINICAL_TRIALS withdrawal · 2017-07-26Clinical Trial Update: Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
A clinical trial comparing continuous glucose monitoring (CGM) and oral glucose tolerance testing (OGTT) in relation to pancreas T2* MRI-det…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma [Phase 1]
Phase I open-label dose-escalation trial of the investigational compound GSK1059615 in patients with solid tumors or lymphoma was terminated…